About
AllRock Bio is a clinical-stage biotechnology company developing a small-molecule pan-ROCK inhibitor to treat cardiopulmonary and fibrotic diseases, including pulmonary hypertension and interstitial lung disease.
Explore AllRock Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.